Pharmaceutical composition for liver injury protection and application thereof

A liver injury and composition technology, applied in the field of pharmaceutical compositions for liver injury protection, to achieve the effects of reducing hepatic steatosis, reducing the number of fibroblasts and lymphocytes, and good anti-hepatic fibrosis activity

Active Publication Date: 2021-11-02
SHAANXI UNIV OF CHINESE MEDICINE
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the principle of treatment of liver fibrosis is to remove the cause and anti-inflammation. The treatment strategies include anti-HSCs activation, collagen degradation and targeted drug therapy, but there is no specific drug for the treatment of liver fibrosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for liver injury protection and application thereof
  • Pharmaceutical composition for liver injury protection and application thereof
  • Pharmaceutical composition for liver injury protection and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The preparation of embodiment 1 Zhengyuanfang water extract

[0037]The traditional Chinese medicine composition preparation is prepared according to the following raw materials in parts by weight: 20 parts of American ginseng, 30 parts of Agrimony, 10 parts of Angelica sinensis, 15 parts of Chonglou, 15 parts of Nansha ginseng, and 10 parts of Platycodon grandiflora, decocting 3 times, each Add 10 times the amount of water for the first time, decoct for 1.5 hours each time for the first two times, and decoct for 1 hour for the third time, combine the water decoctions of the three decoctions, and concentrate under vacuum at 60°C to a relative density of 1.05-1.15 Thick paste, spray-dried, collect the fine powder and all the medicinal powder adhered to the inner wall of the spray dryer, mix well, and obtain the water extract of Zhengyuanfang.

[0038] The American ginseng adopted in the present invention is cool in nature, sweet in taste, slightly bitter, and returns to ...

Embodiment 2

[0039] Example 2 Effect of Zhengyuan Fang water extract on the viability of L02 human normal liver cells

[0040] L02 cells were divided into 1.5×10 5 Each / mL density is inoculated in 96 well plate, overnight, add Zhengyuanfang aqueous extract, make the working concentration of the Zhengyuanfang aqueous extract in each hole be 20, 50, 100, 200, 500, 1000 μ g / mL, After 24 hours, MTT was added to measure the cell viability, and the effect of different concentrations of Zhengyuanfang water extract on the viability of L02 normal human liver cells was determined. For the bar graph of the survival rate of L02 cells, see figure 1 , the present invention found that the water extract of Zhengyuan Fang had a proliferation-promoting effect on human normal liver cell L02 in the range of 100 μg / mL to 500 μg / mL, and the pro-proliferation effect was significant at 500 μg / mL.

Embodiment 3

[0041] Embodiment 3 Zhengyuanfang water extract is to H 2 o 2 Protective effect of induced oxidative damage in L02 hepatocytes

[0042] By the action concentration range of the suitable Zhengyuanfang water extract of result screening in embodiment 2, further pass H 2 o 2 Induce and construct the liver cell oxidative damage model, and measure the survival rate of cells in each group by MTT. For the results, see figure 2 , the present invention finds that Zhengyuan Fang has obvious pro-proliferation effect on normal human liver cells, and hydrogen peroxide H 2 o 2 Induce L02 liver cells to cause oxidative damage model, set H 2 o 2 The concentration was 250μM to injure, after administration, it was found that Zhengyuan Fang had a protective effect on the liver cells damaged by hydrogen peroxide. The living cells in each group were stained by Hoechst 33342 / PI double staining, and the stained cells were observed under the Hoechst33342 fluorescence channel with a fluorescenc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicines, and relates to a pharmaceutical composition for liver injury protection and application thereof, and the pharmaceutical composition for liver injury protection is prepared from the following raw material medicines: American ginseng, hairyvein agrimony, angelica sinensis, paris polyphylla, adenophora tetraphylla and platycodon grandiflorum. The invention provides a pharmaceutical composition for liver injury protection and application thereof, wherein the pharmaceutical composition has good liver cell proliferation promoting activity, liver cell oxidative injury relieving activity and liver fibrosis resisting activity.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a pharmaceutical composition and application thereof, in particular to a pharmaceutical composition for liver damage protection and application thereof. Background technique [0002] Chronic liver disease is a disease with high morbidity and mortality worldwide. Liver fibrosis is caused by various acute or chronic liver diseases, such as viral hepatitis B or C, nonalcoholic fatty liver disease, alcoholic steatohepatitis, nonalcoholic steatohepatitis, biliary tract disease, cholestatic liver disease, etc. Histopathological changes caused by various diseases. Liver injury will lead to hyperactivity of hepatic stellate cells (HSCs), which in turn triggers increased synthesis of extracellular matrix (ECM), excessive deposition of collagen fibers in the extracellular space of hepatocytes, and loss of blood supply to hepatocytes. With proper attention and treatment, liver fibrosis will further d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61P1/16
CPCA61K36/258A61K36/73A61K36/232A61K36/896A61K36/342A61K36/346A61P1/16A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 唐志书周瑞宋忠兴苏洁
Owner SHAANXI UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap